Figure 2From: Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH studyAdditional reductions with T/HCTZ compared with V/HCTZ in mean ambulatory SBP and DBP during various periods of the 24-hour dosing interval after treatment for 10 weeks. Black: SBP; white: DBP.Back to article page